MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours. [electronic resource]
- Targeted oncology 08 2018
- 423-436 p. digital
Publication Type: Journal Article; Review
1776-260X
10.1007/s11523-018-0580-3 doi
Humans MicroRNAs--metabolism Neoplasms--drug therapy Protein Kinase Inhibitors--pharmacology Proto-Oncogene Mas